NCT03928639|Withdrawn
Study Stopped
Due to logistical issues at Emory University enrollment never initiated.
Structural Heart and Valve Network PROSPECTIVE Registry
NHLBI Structural Heart and Valve Network Prospective Registry
Loading search results
Sponsor study identifier
Secondary identifiers
observational
0
1 country
1
Study Start
January 10, 2023
Actual (reported)Primary Completion
January 10, 2023
Actual (reported)Study Completion
January 10, 2023
Actual (reported)Background: Treatments for structural heart and valve disease are quickly changing. But treatment could be improved. Researchers want to gather data from people with this disease. They want to find problems and seek new ways to make treatments better. Objective: To find people with structural heart and valve disease with common features to study. To find flaws and patterns in procedures related to this disease. To share findings with other researchers. Eligibility: People ages 18 and older who are receiving care from the structural heart and valve program at the participating NHLBI structural heart disease network sites that are part of the study Design: Participants will be screened with their consent. This will occur when they give their standard consent for medical care. Participants will have their data collected in the course of standard medical care. Data include: Demographic data Protected health data Personally identifiable data Medical records Medical images. These could include X-rays, CT scans, and MRI scans. The study could find something that would impact participants care. If this is the case, their doctors will be told. Participants data may be shared with other researchers. ...
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 10, 2023
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 25, 2019
Actual (reported)April 26, 2019
Actual (reported)January 10, 2023
Actual (reported)January 10, 2023
Actual (reported)January 10, 2023
Actual (reported)Enrollment
To identify patients with common features of interest for further analysis, for example, of specific types of complications, and identifyshortcomings and patterns in clinical structural heart and valve interventional procedures.
Ongoing
All patients undergoing consultation for structural and valve interventional procedures are invited to participate in this registry protocol.
All patients undergoing consultation for structural and valve interventional procedures, at participating NHLBI structural heart and valve centers, are invited to participate in this registry protocol.
Emory University
Atlanta, Georgia, 30322-1102, United States
Robert J Lederman, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
0 participants (actual enrollment reported by the registry).
First Submitted
April 25, 2019
First Posted
April 26, 2019
Study Start
January 10, 2023
Actual (reported)Efficacy of MitraCLip Vs. PASCAL for the TrEAtment of MitraL REgurgiTation in an All-comer Population
Contact the study team to confirm eligibility.
Primary Completion
January 10, 2023
Actual (reported)Study Completion
January 10, 2023
Actual (reported)Last Updated
January 12, 2023
Record last verified: 2023-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: